What is eScreen?
Founded in 1998 and headquartered in Kansas City, Missouri, eScreen, Inc. operates as a specialized provider of comprehensive drug testing services. The company distinguishes itself through a robust technological framework that facilitates urine, oral fluid, and hair drug testing. Central to its service offering is the Quantisal Lab Oral Fluid Collection Device, a diagnostic tool designed to streamline the collection process while maintaining high standards of accuracy and reliability. By integrating advanced laboratory technology with efficient logistics, eScreen serves as a critical partner for enterprises seeking to maintain rigorous safety and compliance standards across their workforce. The firm's market position is defined by its ability to digitize and automate the drug screening process, effectively reducing turnaround times and administrative burdens for large-scale employers.
How much funding has eScreen raised?
eScreen has raised a total of $8M across 1 funding round:
Series B
$8M
Series B (2008): $8M with participation from The Carlyle Group
Key Investors in eScreen
The Carlyle Group
The Carlyle Group is a global investment firm specializing in private equity with operations across North America, Europe, Asia, Australia, the Middle East, Africa, and Latin America. Founded in 1987, the company manages numerous funds focused on four primary investment disciplines: buyouts, venture and growth capital, real estate, and leveraged finance.
What's next for eScreen?
With the backing of major institutional capital, eScreen is well-positioned to accelerate its operational footprint and enhance its diagnostic capabilities. The current funding context suggests a strategic pivot toward deepening its market penetration in the enterprise sector, where demand for standardized, high-throughput screening remains elevated. Future initiatives will likely focus on the integration of next-generation collection technologies and the expansion of its digital reporting platforms. By leveraging its established infrastructure, the company aims to further solidify its role as a leader in the occupational health space, potentially exploring new diagnostic modalities or expanding its service reach into emerging global markets. The focus remains on maintaining operational excellence while scaling to meet the evolving regulatory and safety requirements of its diverse client base.
See full eScreen company page
